Anand Narasimhan, head of controlling for Asia-Pacific, China, and Japan at Merck, suggests that his business is additionally becoming much more forward-seeking, Though he acknowledges that transform comes more gradually for the legacy pharmaceutical corporation than it'd to a more agile digital startup. In the final handful of decades, however, he